Literature DB >> 22773331

Deadly public policy: what the future could hold for the HIV epidemic among injection drug users in Vancouver.

Michael V O'Shaughnessy1, Robert S Hogg, Steffanie A Strathdee, Julio S G Montaner.   

Abstract

The scope and scale of the HIV outbreak that occurred among injection drug users in Vancouver in the late 1990s was unprecedented and resulted in some 2,000 new HIV infections, with incidence rates reaching 18 per 100 person-years. This outbreak, localized mainly in one neighbourhood, cost the Canadian health care system more than 1 billion dollars to diagnose, care and treat. A number of factors combined to stabilize HIV incidence: 1) HIV prevalence became saturated among those at highest risk; 2) several public health policies focused on drug users were implemented, including increased and additional decentralized needle exchange programs, expanded methadone maintenance services, better addiction treatment services, improved housing, and mental health programs; and 3) increased access and expansion of Highly Active Antiretroviral Therapy. To ensure that a similar outbreak never occurs again in Vancouver and other cities, future health policy must consider the political, psychosocial and socioeconomic factors that contributed to this outbreak. These policies must address the unintended adverse consequences of past policies and their repercussions for marginalized individuals living in this community and beyond.

Entities:  

Mesh:

Year:  2012        PMID: 22773331     DOI: 10.1007/s11904-012-0130-z

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  44 in total

Review 1.  Current review and clinical management of patients with primary HIV-1 infection: limits and perspectives.

Authors:  P Hermans
Journal:  Biomed Pharmacother       Date:  2001-07       Impact factor: 6.529

2.  Attendance at supervised injecting facilities and use of detoxification services.

Authors:  Evan Wood; Mark W Tyndall; Ruth Zhang; Jo-Anne Stoltz; Calvin Lai; Julio S G Montaner; Thomas Kerr
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

Review 3.  The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic.

Authors:  Julio S G Montaner; Robert Hogg; Evan Wood; Thomas Kerr; Mark Tyndall; Adrian R Levy; P Richard Harrigan
Journal:  Lancet       Date:  2006-08-05       Impact factor: 79.321

4.  Changes in injecting practices associated with the use of a medically supervised safer injection facility.

Authors:  Jo-Anne Stoltz; Evan Wood; Will Small; Kathy Li; Mark Tyndall; Julio Montaner; Thomas Kerr
Journal:  J Public Health (Oxf)       Date:  2007-01-17       Impact factor: 2.341

5.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Authors:  Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall
Journal:  Lancet       Date:  2010-07-16       Impact factor: 79.321

6.  Diacetylmorphine versus methadone for the treatment of opioid addiction.

Authors:  Eugenia Oviedo-Joekes; Suzanne Brissette; David C Marsh; Pierre Lauzon; Daphne Guh; Aslam Anis; Martin T Schechter
Journal:  N Engl J Med       Date:  2009-08-20       Impact factor: 91.245

7.  Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.

Authors:  Kevin J P Craib; Patricia M Spittal; Evan Wood; Nancy Laliberte; Robert S Hogg; Kathy Li; Katherine Heath; Mark W Tyndall; Michael V O'Shaughnessy; Martin T Schechter
Journal:  CMAJ       Date:  2003-01-07       Impact factor: 8.262

8.  Sexual violence among a cohort of injection drug users.

Authors:  Paula Braitstein; Kathy Li; Mark Tyndall; Patricia Spittal; Michael V O'Shaughnessy; Arn Schilder; Caitlin Johnston; Robert S Hogg; Martin T Schechter
Journal:  Soc Sci Med       Date:  2003-08       Impact factor: 4.634

9.  Inability to access addiction treatment and risk of HIV infection among injection drug users.

Authors:  Evan Wood; Patricia Spittal; Kathy Li; Thomas Kerr; Cari L Miller; Robert S Hogg; Julio S G Montaner; Martin T Schechter
Journal:  J Acquir Immune Defic Syndr       Date:  2004-06-01       Impact factor: 3.731

10.  Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study.

Authors:  Evan Wood; Thomas Kerr; Brandon D L Marshall; Kathy Li; Ruth Zhang; Robert S Hogg; P Richard Harrigan; Julio S G Montaner
Journal:  BMJ       Date:  2009-04-30
View more
  9 in total

1.  Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs.

Authors:  Jiaming Liang; Ekaterina Nosova; Hudson Reddon; Seonaid Nolan; Eugenia Socías; Rolando Barrios; M-J Milloy
Journal:  AIDS       Date:  2020-07-15       Impact factor: 4.177

2.  Successes and gaps in uptake of regular, voluntary HIV testing for hidden street- and off-street sex workers in Vancouver, Canada.

Authors:  K N Deering; J S Montaner; J Chettiar; J Jia; G Ogilvie; C Buchner; C Feng; S A Strathdee; K Shannon
Journal:  AIDS Care       Date:  2014-11-27

3.  Gaps in the hepatitis C continuum of care among sex workers in Vancouver, British Columbia: Implications for voluntary hepatitis C virus testing, treatment and care.

Authors:  M Eugenia Socías; Kate Shannon; Julio S Montaner; Silvia Guillemi; Sabina Dobrer; Paul Nguyen; Shira Goldenberg; Kathleen Deering
Journal:  Can J Gastroenterol Hepatol       Date:  2015-10-22

Review 4.  The paradigm of universal access to HIV-treatment and human rights violation: how do we treat HIV-positive people who use drugs?

Authors:  Monica Malta; Michelle Ralil da Costa; Francisco Inácio Bastos
Journal:  Curr HIV/AIDS Rep       Date:  2014-03       Impact factor: 5.071

5.  Optimizing an HIV testing program using a system dynamics model of the continuum of care.

Authors:  Sarah Kok; Alexander R Rutherford; Reka Gustafson; Rolando Barrios; Julio S G Montaner; Krisztina Vasarhelyi
Journal:  Health Care Manag Sci       Date:  2015-01-17

6.  Are Low- and Middle-Income Countries Repeating Mistakes Made by High-Income Countries in the Control of HIV for Men who have Sex with Men?

Authors:  Han-Zhu Qian; Sten H Vermund
Journal:  J AIDS Clin Res       Date:  2012

Review 7.  A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015.

Authors:  Michelle Olding; Ben Enns; Dimitra Panagiotoglou; Jean Shoveller; P Richard Harrigan; Rolando Barrios; Thomas Kerr; Julio S G Montaner; Bohdan Nosyk
Journal:  J Int AIDS Soc       Date:  2017-09-19       Impact factor: 5.396

8.  Physicians' patient base composition and mortality among people living with HIV who initiated antiretroviral therapy in a universal care setting.

Authors:  Beverly Allan; Kalysha Closson; Alexandra B Collins; Mia Kibel; Shenyi Pan; Zishan Cui; Taylor McLinden; Surita Parashar; Viviane Dias Lima; Jason Chia; Benita Yip; Rolando Barrios; Julio S G Montaner; Robert S Hogg
Journal:  BMJ Open       Date:  2019-03-20       Impact factor: 2.692

9.  "SALOME gave my dignity back": the role of randomized heroin trials in transforming lives in the Downtown Eastside of Vancouver, Canada.

Authors:  Ehsan Jozaghi
Journal:  Int J Qual Stud Health Well-being       Date:  2014-03-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.